Skip to content

Zandu Abhayarishta in the management of Arsha (Hemorrhoids)

Evaluation of Clinical efficacy of Zandu Abhayarishta in the Management of Arsha (Hemorrhoids) with/without Associated Symptoms - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079516
Enrollment
60
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

Healthcare Division Emami Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from following minimum 3 symptoms from category A and B of symptoms associated with Arsha will be selected for this study. Category A: 1. Swelling (Sotha) 2. Bleeding /Fissure (Raktashrava/ Parikartika) 3. Perianal Pain (Shula) 4. Burning (Daha) 5. Itching/ irritation (kandu) Category B: 6. Loss of appetite (Kshudhanash) 7. Distended abdomen (Anaha) 8. Flatulence (Adhmana) 9. Acidity (Amlodgar) 10. Kosthabadhata (Constipation)

Exclusion criteria

Exclusion criteria: 1.Patients suffering from 3rd /4th degree piles 2.Patients who develop secondary complication of Colitis, intestinal obstruction etc. 3.Any other serious illness e.g., Hepatic/ renal failure/severe anemia. 4.Known hypersensitivity or allergy to one or more of the herbal ingredients 5.Other debilitating neurological or psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Reduction in Haemorrhoidal Symptoms: Evaluate the decrease in severity of symptoms such as pain, bleeding, prolapse, and itching as assessed using a validated grading or symptom severity scale over the study period.Timepoint: 45days

Secondary

MeasureTime frame
Improvement in Quality of Life (QoL): Assess changes in patient-reported QoL using a hemorrhoid-specific QoL questionnaire. Reduction in Recurrence Rate: Measure the recurrence of hemorrhoidal symptoms within the follow-up period. Improvement in Bowel Habits: Evaluate changes in stool consistency, frequency, and straining using a standardized bowel habit questionnaire. Safety Assessment: Monitor adverse effects or tolerability issues with Zandu Abhayarishta and Haritaki. Overall Treatment Satisfaction: Patient-reported satisfaction with the treatment modality, based on a Likert scale or similar metric.Timepoint: 45 days

Countries

India

Contacts

Public ContactDRSANJAY SRIVASTAVA

DR.S.R. RAJASTHAN AYURVED UNIVERSITY JODHPUR

sanjayphyayu@gmail.com09414410383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026